CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

198 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q1 2022.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 99,563,575 shares of 416,598,522 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (26,087,528 shares), BAILLIE GIFFORD & CO (7,787,680 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (7,314,662 shares), PNC Financial Services Group, Inc. (6,361,417 shares), BlackRock Inc. (5,681,073 shares), TWO SIGMA ADVISERS, LP (4,747,800 shares), D. E. Shaw & Co., Inc. (3,870,061 shares), TWO SIGMA INVESTMENTS, LP (3,212,109 shares), GEODE CAPITAL MANAGEMENT, LLC (2,374,939 shares), and GOLDMAN SACHS GROUP INC (2,199,256 shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.